New and updated respiratory syncytial virus (RSV) resources
Home / News & Opportunities / Latest news / Current post
August 13, 2025
The Australian Government Department of Health, Disability and Aging (the department) has released a number of updated resources to support the correct administration of RSV vaccines and monoclonal antibodies.
A single dose of the RSV vaccine, Abrysvo®, is recommended for women at 28 to 36 weeks of pregnancy and is available for free through the National Immunisation Program (NIP).
- Arexvy® must not be administered to pregnant women.
- Victoria is offering the RSV monoclonal antibody, Beyfortus™ (Nirsevimab) for free to eligible infants and children.
- Abrysvo® and Arexvy® must not be administered to infants or children.
- The department has produced a poster outlining the correct administration of RSV vaccines and monoclonal antibodies by cohort.
Updated resources include:
- RSV vaccine and monoclonal antibody poster – to facilitate appropriate choice of product
- RSV provider advice fact sheet
- RSV consumer advice fact sheet
- RSV frequently asked questions fact sheet.
For more information visit - Respiratory syncytial virus (RSV) vaccine | Australian Government Department of Health, Disability and Ageing
Latest news
South Eastern Melbourne Primary Health Network (SEMPHN) is pleased to be offering one-off grants to support activities that build the Victorian Jewish community's resilience, wellbeing, and social cohesion .
Data cleansing ensures your mental health register is accurate, up-to-date, and supports high-quality care, QI reporting, and compliance. The process involves identifying and archiving inactive patients, correcting missing or uncoded data, and ensuring all relevant clinical information is coded and current.
The Australian Government has launched the National Menopause and Perimenopause Awareness Campaign to improve access to reliable information and support for women aged 35 and over who are going through this life stage.
